Cue Biopharma stock rallies nearly 40% on upcoming presentations

seekingalpha10-05

Cue Biopharma (NASDAQ:CUE) shares rallied nearly 40% Friday after the company announced it plans to deliver oral and poster presentations for its Immuno-STAT drug candidates CUE-101 and CUE-102 at an ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2473991909?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1455743464/image_1455743464.jpg","is_english":true,"pubTime":"2024-10-05 03:39","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2473991909","market":"sh","top_or_hot":-1,"title":"Cue Biopharma stock rallies nearly 40% on upcoming presentations","media":"seekingalpha","content":"<div>\n<p>Cue Biopharma (NASDAQ:CUE) shares rallied nearly 40% Friday after the company announced it plans to deliver oral and poster presentations for its Immuno-STAT drug candidates CUE-101 and CUE-102 at an ...</p>\n\n<a href=\"https://seekingalpha.com/news/4156544-cue-biopharma-stock-rallies-on-upcoming-presentations\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cue Biopharma stock rallies nearly 40% on upcoming presentations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCue Biopharma stock rallies nearly 40% on upcoming presentations\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-05 03:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4156544-cue-biopharma-stock-rallies-on-upcoming-presentations><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cue Biopharma (NASDAQ:CUE) shares rallied nearly 40% Friday after the company announced it plans to deliver oral and poster presentations for its Immuno-STAT drug candidates CUE-101 and CUE-102 at an ...</p>\n\n<a href=\"https://seekingalpha.com/news/4156544-cue-biopharma-stock-rallies-on-upcoming-presentations\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://seekingalpha.com/news/4156544-cue-biopharma-stock-rallies-on-upcoming-presentations","article_id":"2473991909","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1455743464/image_1455743464.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2473991909","pubTimestamp":1728070748,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Cue Biopharma (NASDAQ:CUE) shares rallied nearly 40% Friday after the company announced it plans to deliver oral and poster presentations for its Immuno-STAT drug candidates CUE-101 and CUE-102 at an ","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","CUE":"Cue Biopharma, Inc."},"translate_title":"Cue Biopharma股价因即将发布的演示而上涨近40%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CUE":0.9},"content_text":"Cue Biopharma (NASDAQ:CUE) shares rallied nearly 40% Friday after the company announced it plans to deliver oral and poster presentations for its Immuno-STAT drug candidates CUE-101 and CUE-102 at an upcoming medical meeting. The biotech company said it will present data from a Phase 1 study of CUE-101 in the treatment of recurrent/metastatic HPV16+ head and neck squamous cell cancer. It also plans to present data from a Phase 1 study of CUE-102 in certain patients with WT1-positive recurrent/metastatic cancers.  Cue (CUE) will make the presentations at the Society for Immunotherapy of Cancer’s 39th Annual Meeting, which will be held in Houston, Texas, from Nov. 6 to Nov. 10, according to a statement.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2473991909"}